BWS
UTHR icon

Buck Wealth Strategies’s United Therapeutics UTHR Stock Holding History

Buck Wealth Strategies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08K Buy
+2
New +$1.13K ﹤0.01% 929

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Buck Wealth Strategies's UTHR Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in United Therapeutics (UTHR) in Q2 2026: 2 shares worth $1.08K. The stake represents ﹤0.01% of the portfolio and ranks #929 among its holdings.

450 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Buck Wealth Strategies held 2 shares of United Therapeutics worth $1.08K as of Q2 2026.
  • United Therapeutics was a new Buck Wealth Strategies position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #929 holding.
  • 450 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.